CIXING(SZ:300307) Zhong Guo Jing Ji Wang·2025-08-04 06:36Core Viewpoint - Cixing Co., Ltd. has decided to terminate the planned acquisition of 75% of Shenyang Shunyi Technology Co., Ltd. through the issuance of shares and cash payment due to failure to reach an agreement on certain commercial terms with some transaction parties [1][2][4]. Group 1: Transaction Details - The planned transaction involved purchasing 75% of Shunyi Technology's shares and raising matching funds from no more than 35 specific investors [1][2]. - The cash payment portion of the transaction was not to exceed 40% of the total transaction price [2][3]. - The issuance price for the shares was set at 7.16 yuan per share, which is not lower than 80% of the average trading price over the previous 120 trading days [3][4]. Group 2: Financial Information - Shunyi Technology's revenue for the years 2023, 2024, and the first quarter of 2025 was reported as 283.92 million yuan, 224.55 million yuan, and 2.84 million yuan, respectively, with net profits of 27.72 million yuan, 54.88 million yuan, and a loss of 11.78 million yuan [5]. - Cixing Co., Ltd. reported a revenue of 608 million yuan in the first quarter of 2025, a year-on-year increase of 2.73%, but a significant decrease in net profit by 66.46% [6]. Group 3: Company Background - Shunyi Technology is recognized as a high-tech enterprise specializing in the development, production, and sales of health management systems and intelligent detection equipment, primarily serving the defense technology sector [4][5]. - The actual controller of Shunyi Technology, Li Yingshun, holds 58.20% of the shares and has significant influence over the company's decisions [5].